Amlodipine And Valsartan Tablet, Film Coated
Product Images NDC 0378-1722

7 FDA label images from Mylan Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 0378-1722). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine And Valsartan Figures 01 (04)

Amlodipine And Valsartan Figures 01 (04)
Set of four graphs showing the probability of achieving target systolic and diastolic blood pressure at Week 8. The charts compare amlodipine and valsartan 10 mg/320 mg, valsartan 320 mg, amlodipine 10 mg, and placebo across varying baseline systolic and diastolic blood pressures. Each figure depicts the percentage achieving specific blood pressure thresholds relative to baseline values.*
FDA Label Image

Amlodipine Besylate Structural Formula (Image 02)

Amlodipine Besylate Structural Formula (Image 02)
Chemical structure diagram showing the molecular configuration of the active ingredient amlodipine, with labeled aromatic rings, functional groups including chlorine, methoxy, ester, and amine groups. It is part of the AMLODIPINE AND VALSARTAN product.*
FDA Label Image

Valsartan Structural Formula (Image 03)

Valsartan Structural Formula (Image 03)
Chemical structure of amlodipine as part of the active ingredients amlodipine and valsartan in the drug product. The diagram shows the molecular arrangement including rings and functional groups.*
FDA Label Image

Amlodipine And Valsartan Tablets, Usp 5 mg/160 mg Bottle Label (Image 04)

Amlodipine And Valsartan Tablets, Usp 5 mg/160 mg Bottle Label (Image 04)
Label for AMLODIPINE AND VALSARTAN tablets, USP, 5 mg / 160 mg strength, film-coated oral tablets by Mylan Pharmaceuticals Inc. The label includes dosage strength, manufacturer information, storage instructions, and child safety warnings. It also displays the NDC 0378-1721-93, a brown, oval tablet imprinted with MX1, a barcode, and a note about a child-resistant container.*
FDA Label Image

Amlodipine And Valsartan Tablets, Usp 10 mg/160 mg Bottle Label (Image 05)

Amlodipine And Valsartan Tablets, Usp 10 mg/160 mg Bottle Label (Image 05)
Label for Amlodipine and Valsartan tablets, USP, 10 mg/160 mg strength. The film-coated tablets are oval-shaped, marked with 'MX2'. Package contains 30 tablets. Manufactured by Mylan Pharmaceuticals Inc., Morgantown, WV, USA. The label includes dosage storage instructions and child safety warnings. NDC 0378-1722-93.*
FDA Label Image

Amlodipine And Valsartan Tablets, Usp 5 mg/320 mg Bottle Label (Image 06)

Amlodipine And Valsartan Tablets, Usp 5 mg/320 mg Bottle Label (Image 06)
Label for Amlodipine and Valsartan film-coated tablets by Mylan Pharmaceuticals Inc. It shows the dosage strength as 5 mg Amlodipine/320 mg Valsartan, with a tablet image marked 'MX43'. The label includes storage instructions, dosage warnings, Rx only designation, and a 30 tablet count. It features the Mylan logo and a barcode.*
FDA Label Image

Amlodipine And Valsartan Tablets, Usp 10 mg/320 mg Bottle Label (Image 07)

Amlodipine And Valsartan Tablets, Usp 10 mg/320 mg Bottle Label (Image 07)
Label for Mylan Pharmaceuticals' Amlodipine and Valsartan film-coated tablets, USP, containing 10 mg amlodipine and 320 mg valsartan per tablet. The label indicates a package of 30 tablets, with storage and safety instructions, a barcode, and space for lot and expiration date coding. Manufacturing is in Morgantown, WV, and the product is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.